BARSOTTI, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 11.193
AS - Asia 1.099
NA - Nord America 625
SA - Sud America 70
AF - Africa 17
Totale 13.004
Nazione #
IT - Italia 10.988
US - Stati Uniti d'America 583
SG - Singapore 508
CN - Cina 265
VN - Vietnam 196
FR - Francia 93
BR - Brasile 40
HK - Hong Kong 40
FI - Finlandia 21
CH - Svizzera 19
MX - Messico 18
AR - Argentina 17
GB - Regno Unito 17
DE - Germania 16
CA - Canada 13
IN - India 13
BD - Bangladesh 12
IQ - Iraq 12
JP - Giappone 10
RU - Federazione Russa 8
PK - Pakistan 7
NL - Olanda 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
EC - Ecuador 5
ID - Indonesia 5
PH - Filippine 5
IE - Irlanda 4
KR - Corea 4
TH - Thailandia 4
CR - Costa Rica 3
ES - Italia 3
SA - Arabia Saudita 3
UA - Ucraina 3
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
SE - Svezia 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
PL - Polonia 1
PT - Portogallo 1
SN - Senegal 1
TR - Turchia 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 13.004
Città #
Genova 6.503
Genoa 2.472
Rapallo 1.228
Vado Ligure 725
San Jose 265
Singapore 255
Lauterbourg 85
Ho Chi Minh City 63
Hanoi 45
Ashburn 39
New York 37
Beijing 36
Hong Kong 35
Bordighera 30
Santa Clara 23
Helsinki 21
Zurich 19
Frankfurt am Main 14
Los Angeles 14
Orem 13
Mexico City 11
Da Nang 10
Tianjin 10
Tokyo 10
Chennai 7
Dallas 6
Guangzhou 6
Haiphong 6
São Paulo 6
Amsterdam 5
London 5
Phoenix 5
Poplar 5
Dublin 4
Manchester 4
Milan 4
Montreal 4
Paris 4
Quito 4
Rome 4
Baghdad 3
Biên Hòa 3
Buffalo 3
Campinas 3
Can Tho 3
Chicago 3
Chongqing 3
Cincinnati 3
Houston 3
Hải Dương 3
Johannesburg 3
San José 3
São Bernardo do Campo 3
Atlanta 2
Bengaluru 2
Bắc Giang 2
Cape Town 2
Casablanca 2
Charlotte 2
City of London 2
Concepción 2
Council Bluffs 2
Dubai 2
Go Vap 2
Guarulhos 2
Jandira 2
Kyiv 2
Lafayette 2
Lahore 2
Ljubljana 2
Louisville 2
Mauá 2
Memphis 2
Miami 2
Ninh Bình 2
Nuremberg 2
Panama City 2
Phú Nhuận 2
Queens 2
Quảng Ngãi 2
San Francisco 2
St Petersburg 2
Stockholm 2
Toronto 2
Tunis 2
Acalanes Ridge 1
Aix-en-Provence 1
Al Qaţīf 1
Amarillo 1
Arcoverde 1
Arlington 1
Arroio Grande 1
Ban Mi 1
Bangkok 1
Banqiao 1
Bari 1
Benito Juarez 1
Bishkek 1
Biñan 1
Bloomer 1
Totale 12.160
Nome #
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 230
ACE inhibitors can induce circulating antibodies directed to antigens of the superficial epidermal cells. 213
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 197
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 195
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 187
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 182
Increased neutrophil lifespan in patients with congestive heart failure. 179
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 179
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 178
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 177
Associazione tra lipoperossidazione ed insorgenza giovanile di aterosclerosi coronarica. 177
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. 175
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 175
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy 175
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 174
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 173
Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy. 171
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 168
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 163
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 161
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 158
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 155
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. 153
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 153
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 151
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 149
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 147
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 146
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 146
Early Age of onset of unstable angina is associated to major oxidative stress 146
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 146
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 145
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 144
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 143
Biliopancreatic diversion reduces QT interval and dispersion in morbidly obese patients 142
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 139
MR EVALUATION OF CORONARY STENTS WITH NAVIGATOR ECHO AND BREATH-HOLD CINE GRADIENT-ECHO TECHNIQUES 137
ALTERAZIONI DELLE PROTEINE TELOMERICHE E SENESCENZA: UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ DA ANTRACICLINE 135
OxLDL- and HSP-60 antigen-specific CD8(+) T lymphocytes are detectable in the peripheral blood of patients suffering from coronary artery disease. 135
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 134
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 131
N-acetyl-cysteine Regulates the Response to Injury in NZW Rabbit Aorta. 131
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities 129
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 129
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 128
Early age of onset of unstable angina is associated with major oxidative stress 128
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 128
A PATHOGENETIC HYPOTHESIS ABOUT ELECTRIC STORM. 127
Accuracy of noninvasive monitoring of coronary flow velocity reserve with transthoracic echo-doppler in detecting coronary restenosis after successfull coronary angioplasty: a multicenter study 124
Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. 124
PROGENITOR CD34+ CELLS AND CIRCULATING ENDOTHELIAL CELLS IN PATIENTS WITH ACUTE OR CHRONIC HEART FAILURE 121
Osteopontin plasma levels correlate with coronary atherosclerosis extension and in-stent restenosis in coronary artery disease patients undergoing percutaneous coronary intervention 120
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 119
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 118
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 117
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 116
Improved assessment of left ventricular volumes and ejection fraction by contrast enhanced harmonic color Doppler echocardiography 116
LA DOXORUBICINA ALTERA L’ESPRESSIONE DELL’IGF-1R E DELL’IGFBP3 IN CELLULE MUSCOLARI CARDIACHE. UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ 114
Cor triatratum sinistrum and persistent left superior vena cava: an original association. 113
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 110
Doxorubicin induces activation of Metalloproteinase-2 and –9 in cardiomyocytes through the MAPKinase pathways: protective effects of carvedilol and dexrazoxane 110
Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy 109
Elevata attivita’ di metalloprteasi 2 e 9 circolanti nei pazienti con scompenso cardiaco 105
Oxidative stress, apoptosis and immunological activation in acute myocardial infarction 105
Coronary aneurysms and stenosis detected with magnetic resonance coronary angiography in a patient with Kawasaki disease. 104
Thrombus determinants of vascular cell activation. 104
IL SIERO POSTPRANDIALE MOSTRA EFFETTI PRO-OSSIDANTI E PROAPOPTOTICI SULLE CELLULE ENDOTELIALI 103
Il carvedilolo previene la perdita del potenziale di membrana mitocondriale indotta da doxorubicina nei cardiomiociti 103
Transcatheter occlusion of PFO and ASD in cryptogenic stroke 102
La doxorubicina induce apoptosi e senescenza nei progenitori delle cellule endoteliali e regola l'azione chemiotattica dei cardiomiociti nei loro confronti 102
Traditional risk factors for ATS do not explain major oxidative stress levels in patients with early age onset of unstable angina: possibile role for genetic factors? Population genetics of haemostatic risk factors for arterial vascular disease. 101
Un pasto iperlipidico rende il siero pro-apoptotico per le cellule endoteliali: ruolo dell’infiammazione e stress ossidativo. 100
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study 100
Insorgenza precoce di angina instabile e livelli plasmatici di perossidazione lipidica 99
Meccanismi di tossicità indotta da doxorubicina su cardiomiociti e razionale per l’uso dei farmaci protettivi nella pervenzione del danno cardiaco 97
Doxorubicin induces LOX-1 expression in cardiac myocytes via oxidative stress: role of cardioprotective agents 97
Time-course of acute myocardial infarction-dependent peripheral mobilisation of endothelial progenitor cells 97
Il carvedilolo protegge le cellule endoteliali contro la produzione di radicali liberi e l’apoptosi indotte da doxorubicina. 97
Markers of oxidative stress evaluated in patients with ischemic heart disease at the time of their first clinical manifestation. 96
Ruolo del Polimorfismo C242T della Subunità p22phox del Complesso NAD(P)H Ossidasi in Pazienti con Aterosclerosi Coronarica. 95
Relazione tra Stress Parietale e Risposta Infiammatoria Sistemica con Danno Miocardico in pazienti con Insufficienza Cardiaca Cronica in fase Stabile 94
Il carvedilolo previene la formazione di radicali liberi e il danno ossidativo indotto da doxorubicina sui cardiomiociti. 93
STRESS OSSIDATIVO E P53 MEDIANO L’INIBIZIONE DI IGF-1R INDOTTA DA DOXORUBICINA IN CELLULE MUSCOLARI CARDIACHE 92
Pazienti con manifestazione precoce di angina instabile non presentano correlazioni tra livelli di stress ossidativo e autoanticorpi diretti contro proteine ossidate. 92
Mobilizzazione ematica di sottopopolazioni di progenitori di cellule endoteliali in pazienti con infarto acuto del miocardio 91
Dispersione del QT in Soggetti con Insufficienza Renale Cronica Trattati con Dialisi Peritoneale o con Emodialisi. 90
Prevalence of persistent left superior vena cava and its implication in pacemaker implantation 90
Evaluation of Xa/Va activity bound to platelet-rich thrombi in patients with acute coronary syndromes 90
Myocardial magnetic resonance spectroscopy 87
Polimorfismo nel gene cyba: possibile marcatore di suscettibilita’ genetica all’aterosclerosi 85
Up-regulation of lectin-like oxidised LDL receptor-1 (LOX-1) in cardiac muscle cells and implications in doxorubicin-induced cardiotoxicity. 85
Neutrophil-derived matrix metalloproteinase 9 is increased in patients with heart failure 83
La doxorubicina induce le metalloproteasi 2 e –9 attraverso l’attivazione delle MAPK: ruolo protettivo del carvedilolo e del dexrazoxane., 82
La doxorubicina induce l’espressione di LOX-1R in cellule muscolari cardiache attraverso un incremento dello stress ossidativo: ruolo di molecole cardioprotettive 82
Effetto protettivo del carvedilolo contro la morte per apoptosi indotta da doxorubicina in cellule muscolari cardiache. 81
Involvement of neutrophils and of C-C chemokines in chronic heart failure 80
TRATTAMENTI SEQUENZIALI CON DOSI SUB-APOPTOTICHE DI EPIDOXORUBICINA ED ANTICORPO ANTI erbB2 INDUCONO APOPTOSI NEI CARDIOMIOCITI: RUOLO CARDIOPROTETTIVO DEL DEXRAZOXANE. 77
La doxorubicina induce l’aumento della trascrizione e dell’attività della MMP-2 nelle cellule muscolari cardiache attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 76
SUBSET MONOCITARI CD14 CD16 IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO. 73
Primary percutaneous transluminal angioplasty in the setting of multivessel disease 70
Totale 12.695
Categoria #
all - tutte 38.703
article - articoli 31.573
book - libri 0
conference - conferenze 7.130
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/20221.205 9 102 84 159 68 65 76 308 23 121 45 145
2022/20231.430 130 78 6 161 280 239 6 106 231 5 165 23
2023/2024598 23 83 10 54 52 129 37 37 59 7 32 75
2024/20251.727 46 128 59 137 258 163 145 240 56 79 180 236
2025/20262.746 382 60 99 214 311 321 566 138 158 326 99 72
Totale 13.017